Blog.
Notes on AI, drug discovery, and building platforms in biomedicine. Short posts. No listicles. Occasional diagrams.
2026
AI drug discovery is finally on trial. Both verdicts are already being written.
10 Aug 2026·12 min readRentosertib — AI-discovered target, AI-designed molecule — entered a pivotal Phase III in July. Fifteen to twenty more programs may follow this year. The boosters will over-read a success, the sceptics will over-read a failure, and both will be making the same statistical mistake. A field guide to reading the class of 2026 honestly.
Aging Reversal Is Real Science. The Hard Part Isn't What You Think.
28 Apr 2026·16 min readA biologist-turned-AI-guy on what the rejuvenation field actually proves, what it doesn't, and why the "is this even possible" question has a clear answer.
Pharma's complexity demands more than AI — it needs bilingual experts
12 Apr 2026·6 min readThe bottleneck in AI for drug development is no longer the model. It is the shortage of people who can hold the clinical, regulatory and computational picture in their head at the same time — and frame the question before anyone writes a line of code.